How to Microdose Psilocybin: A Step-by-Step Guide

Microdosing psilocybin means taking a very small amount of dried psilocybin mushrooms — typically between 0.1 and 0.3 grams — on a regular schedule, with rest days between doses. The dose is sub-perceptual: no hallucinations, no impairment, no obvious high. The goal is a subtle background shift in mood, focus, or anxiety that accumulates over weeks rather than producing any single dramatic effect.

This guide covers how to do it practically — doses, schedules, what to track, and what to watch for — as well as the risks and legal realities most step-by-step guides bury at the bottom.

Psilocybin mushrooms are a Schedule I controlled substance in the United States and are illegal in most countries regardless of dose size. Several US cities — including Denver, Oakland, and Seattle — have decriminalized possession, meaning it's a low enforcement priority. Oregon and Colorado have established regulated frameworks for supervised therapeutic use, but those aren't designed for personal microdosing.

Understand your local legal context before proceeding. Decriminalization is not legalization.

There are also medical contraindications worth stating plainly. Microdosing is not recommended for people with a personal or family history of psychosis, schizophrenia, or bipolar disorder — even sub-perceptual doses carry real risk for this population. Anyone taking lithium should avoid psilocybin entirely; the combination has been associated with seizures. If you're on SSRIs — selective serotonin reuptake inhibitors, a common class of antidepressants — psilocybin's effects may be blunted or unpredictable, and stopping SSRIs to microdose carries its own risks. Talk to a doctor before making any medication changes.

[INTERNAL LINK: Is Microdosing Legal? What You Need to Know]

Psilocybin mushrooms aren't a pharmaceutical — potency varies between species, between batches, and even within the same batch. Psilocybe cubensis is the most common species used for microdosing, widely available in places where possession is decriminalized or tolerated.

Preparing consistent doses requires a few things: a kitchen scale accurate to 0.01 grams (standard postal scales won't do — spend the extra money on a precision scale), dried mushrooms with as little moisture variation as possible, and ideally a grinder to turn dried mushrooms into a uniform powder. Grinding and then weighing produces more consistent doses than weighing whole or broken pieces, because density varies.

Some people encapsulate their ground mushrooms using empty gel capsules — a practical approach that removes the taste and makes dosing quicker. This isn't necessary, but it does reduce the small ritual element that can introduce expectation bias.

The standard starting range for psilocybin microdosing is 0.1 to 0.3 grams of dried mushrooms. That's a wide window — and the right starting point is the low end, not the middle.

Start at 0.1 grams. Take it on a morning when you have no important commitments, so you can observe your response without pressure. A true microdose should feel like essentially nothing in terms of perceptual change. If you notice any visual softening, mood elevation that feels distinctly drug-like, or difficulty concentrating, the dose is too high.

After your first week at 0.1 grams, you can adjust. Most people find their sweet spot somewhere between 0.1 and 0.2 grams. A small number find even 0.1 grams too stimulating and do better at 0.05. A smaller number need 0.3 grams to notice any effect at all. Individual variation is real and significant — treat the numbers as a starting framework, not a prescription.

The most widely used schedule is the Fadiman Protocol: dose on Day 1, rest on Days 2 and 3, dose again on Day 4. The two rest days prevent tolerance buildup and give you a baseline to compare against.

[INTERNAL LINK: The Fadiman Protocol: What It Is and How It Works]

An alternative is the Stamets Stack — a combination of psilocybin, lion's mane mushroom, and niacin, taken five days on and two days off. The specific combination is less studied than the Fadiman schedule but has a large following.

[INTERNAL LINK: What Is a Microdosing Stack? The Paul Stamets Protocol Explained]

Whichever protocol you follow, dose in the morning. Both psilocybin and LSD have mild stimulant properties even at sub-perceptual levels, and afternoon or evening dosing reliably disrupts sleep for a significant portion of people.

Run the protocol for four to eight weeks. Then take a full break — at least two to four weeks — before assessing whether to continue. The break lets tolerance reset completely and gives you a real before-and-after comparison.

This is the part most guides mention and most people skip. Don't skip it.

The Fadiman Protocol was designed around self-observation. Without a consistent record across dose days, transition days, and normal days, you're left with a general impression at the end of eight weeks rather than actual data about what changed and when.

Track the same things every day, briefly: mood, energy, focus, anxiety, sleep quality, and any notable social or creative experiences. You don't need to write much — a few lines or a numerical rating for each category is enough. The point is consistency.

At the end of a cycle, patterns emerge that aren't visible day-to-day. Most people find their dose-day experience unremarkable in the moment; the journal shows the comparison.

Not everyone responds well to microdosing, and knowing what to look for matters.

Increased anxiety. Some people find psilocybin amplifies anxiety rather than reducing it, even at very low doses. If anxiety is consistently worse on dose days, the substance may not be a good fit — or the dose is too high.

Emotional amplification. Microdosing appears to intensify whatever emotional state is already present. During periods of high stress, grief, or difficulty, this can make things harder rather than easier.

Sleep disruption. If you're dosing in the morning and still noticing sleep changes, try reducing your dose before changing your schedule.

Diminishing returns. Some people find that after several weeks, the protocol stops producing any noticeable effect. This is a signal to take a break, not to increase the dose.

If any experience feels unmanageable or significantly distressing, stopping is the right call. A microdose should never feel overwhelming — if it does, something is off.

Most people who report positive results from microdosing don't describe a dramatic transformation. They describe a reduction in friction — slightly easier mornings, a little more patience, fewer hours lost to low mood or anxious cycling. The effect, when it's working, tends to be most visible in retrospect.

The research supports a modest version of this picture. Survey data consistently shows meaningful improvements in depression and stress over microdosing cycles. Creativity improvements — one of the most commonly cited reasons people start — are less reliably documented in controlled studies.

[INTERNAL LINK: Microdosing Benefits: What Users Report] [INTERNAL LINK: What Is Microdosing Research Actually Showing?]

Microdosing is not a treatment for clinical depression or anxiety, and using it as a substitute for professional mental health care is not what the evidence supports. For people already in therapy or working with a psychiatrist, it may be worth discussing — but the conversation belongs in a clinical context, not a forum.

[INTERNAL LINK: What Is Microdosing? A Beginner's Guide]